Incepta says has capacity to produce 1.2bn vaccines a year | The Business Standard
Skip to main content
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Friday
May 23, 2025

Sign In
Subscribe
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
FRIDAY, MAY 23, 2025
Incepta says has capacity to produce 1.2bn vaccines a year

Health

TBS Report
18 March, 2021, 08:10 pm
Last modified: 19 March, 2021, 01:50 pm

Related News

  • Umrah pilgrims struggle with abrupt meningitis vaccination requirement amid shortage
  • Vaccination, early screening can prevent cervical cancer death for women
  • Study on Bangladeshi children confirms lasting impact of typhoid vaccine
  • No doctor necessary: US okays nasal spray flu vaccine for self-use
  • First patient receives lung cancer vaccine in global trial

Incepta says has capacity to produce 1.2bn vaccines a year

‘We are the only pharmaceutical company in the country that manufactures vaccines using state-of-the-art technology in compliance with safety protocols’

TBS Report
18 March, 2021, 08:10 pm
Last modified: 19 March, 2021, 01:50 pm
Incepta says has capacity to produce 1.2bn vaccines a year

Incepta Pharmaceuticals authorities say it has the capacity to produce 1.2 billion single doses of bacterial and viral vaccines.

If approved, the company will be able to make Covid-19 vaccine in the country, said the company.

Health Minister Zahid Maleque visited the Incepta vaccine plant on Thursday and the company's Chairman and Managing Director Abdul Muktadir gave journalists a presentation on how to make a vaccine.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

Muktadir said they had four German technology filling lines and it is possible for them to produce 400 million single doses of vaccines per line every year.

"So, it is possible to make 1.2 billion doses of vaccines here every year, even if it is Covid-19 vaccine, since we also have a cold chain to store 500 million doses of vaccines," he maintained.

Muktadir claimed that they are the only pharmaceutical company in Bangladesh that manufactures vaccines using state-of-the-art technology in compliance with safety protocols.

"Now if we get a bulk of corona vaccines, we will be able to go into production in two weeks, however, once the master seed is obtained, it can take about 12 weeks to go into production," he said.

In this case, the government cooperation is needed because if the government does not want, it is not possible to bring the vaccine in the country alone, said the Incepta managing director.

While inspecting the factory, Health Minister Zahid Maleque said the government would provide all kinds of assistance to the private sector if the country could produce world-class vaccines as per the Good Manufacturing Practice.

In this case, not only Incepta, the government is willing to help any private organisation, he added.

Incepta has already earned the trust of all by creating multiple life-saving vaccines, the minister noted, saying any opportunity to produce coronavirus vaccine in Bangladesh will actually put the drug company ahead in terms of preparation.

The prime minister herself is sincere about the production of corona vaccine in the country, Zahid said, adding, "We are buying 30 million vaccines from Serum, but it will not meet our needs.

"In this case, the premier has asked me to check the capability of private firms."

The government will buy the vaccine if any local firm can provide it according to the policy of the World Health Organisation, said the minister.

"If Incepta can provide us with a quality vaccine, we will consider it. We have some limitations, but we are working on them," he added.

Meanwhile, Major General Mahbubur Rahman, director general of the Department of Drug Administration, said, "We have already written to the World Health

Organization and Oxford- AstraZeneca for vaccine bulk or master seed for vaccine production in the country.

"I hope they will tell us something positive. We are also in discussion with others."

Incepta says the company's vaccine production capability is not being fully utilised now. About half its capacity (628 million) is being used.

Incepta is the first life-saving international standard vaccine manufacturer in Bangladesh. Its vaccine factory in Savar officially started its journey in June 2011.

The company is producing and marketing more than 10 vaccines including rabies, rabies-IG, hepatitis B, typhoid, tetanus, tetanus-IG, measles-rubella, antivenom, flu and meningitis.

Incepta has been making these vaccines for the country as well as exporting them to 12 countries of the world.
 

Bangladesh / Top News

Incepta / Vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Illustration: TBS
    Prof Yunus considering resignation: Nahid tells BBC Bangla after meeting CA
  • Ahmed Shayan Fazlur Rahman. File Photo: Collected
    UK crime agency freezes London properties of Salman F Rahman’s son Shayan: Financial Times report
  • Protesting NBR officials hold a press briefing in Agargaon, Dhaka on 18 May 2025. Photo: TBS
    Amendment to ordinance: Protesting NBR officials welcome move, but say strike will continue

MOST VIEWED

  • How Renata's Tk1,000cr investment plan became a Tk1,400cr problem
    How Renata's Tk1,000cr investment plan became a Tk1,400cr problem
  • Govt officials to get up to 20% dearness allowance
    Govt officials to get up to 20% dearness allowance
  • File Photo: Mumit M/TBS
    Bangladesh to introduce new banknotes before Eid-ul-Adha
  • National Security Adviser Khalilur Rahman speaks at a press briefing at the Foreign Service Academy on 21 May 2025. Photo: PID
    No talks on Myanmar corridor, only discussed channelling aid with UN: Khalilur Rahman
  • Protestors block the intersection in front of InterContinental Dhaka on 22 May 2025. Photo: Syed Zakir Hossain/TBS
    Traffic at a standstill amid multiple protests on city streets
  • NBR officials hold press conference on 21 May 2025. Photo: TBS
    NBR officials announce non-cooperation from today, call for nationwide strike from Saturday

Related News

  • Umrah pilgrims struggle with abrupt meningitis vaccination requirement amid shortage
  • Vaccination, early screening can prevent cervical cancer death for women
  • Study on Bangladeshi children confirms lasting impact of typhoid vaccine
  • No doctor necessary: US okays nasal spray flu vaccine for self-use
  • First patient receives lung cancer vaccine in global trial

Features

Shantana posing with the students of Lalmonirhat Taekwondo Association (LTA), which she founded with the vision of empowering rural girls through martial arts. Photo: Courtesy

They told her not to dream. Shantana decided to become a fighter instead

1d | Panorama
Football presenter Gary Lineker walks outside his home, after resigning from the BBC after 25 years of presenting Match of the Day, in London, Britain. Photo: Reuters

Gary Lineker’s fallout once again exposes Western media’s selective moral compass on Palestine

2d | Features
Fired by US aid cuts, driven by courage: A female driver steering through uncertainty

Fired by US aid cuts, driven by courage: A female driver steering through uncertainty

2d | Features
Photo: TBS

How Shahbagh became the focal point of protests — and public suffering

3d | Panorama

More Videos from TBS

Professor Yunus 'thinking about resigning': Nahid Islam

Professor Yunus 'thinking about resigning': Nahid Islam

42m | TBS Today
Chinese youth now more interested in economic reconstruction than Taiwan issue

Chinese youth now more interested in economic reconstruction than Taiwan issue

1h | Others
How did Musk become Trump's political weapon?

How did Musk become Trump's political weapon?

3h | Others
BNP wants elections and resignation of questionable advisors within this year

BNP wants elections and resignation of questionable advisors within this year

5h | TBS Today
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net